Probing the Protein Kinases' Cysteinome by Covalent Fragments
Covalent Modifiers
DECEMBER 27, 2024
Guiqun Wang, Nico J. Seidler, Sandra Rhm, Yufeng Pan, Xiaojun Julia Liang, Lisa Haarer, Benedict-Tilman Berger, Saran Aswathaman Sivashanmugam, Valentin R. Wydra, Michael Forster, Stefan A. Laufer, Apirat Chaikuad, Matthias Gehringer, Stefan Knapp Angew. Chem. Int. Ed. 2024 , e202419736 [link] Protein kinases are important drug targets, yet specific inhibitors have been developed for only a fraction of the more than 500 human kinases.
Let's personalize your content